About Famotidine API
Therapeutic CategoryGastro-Intestinal - GI
CAS Number
76824-35-6
API Technology
Synthetic
Dose Form
Oral Solids
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted
Mechanism of Action
Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion. Both the acid concentration and volume of gastric secretion are suppressed by famotidine, while changes in pepsin secretion are proportional to volume output.
Related APIs
Esomeprazole Magnesium Trihydrate
Gastro-Intestinal - GI
Famotidine
Gastro-Intestinal - GI
Lubiprostone
Gastro-Intestinal - GI
Nizatidine
Gastro-Intestinal - GI
Omeprazole
Gastro-Intestinal - GI
Omeprazole Magnesium
Gastro-Intestinal - GI
Pantoprazole Sodium
Gastro-Intestinal - GI
Rabeprazole Sodium (Amorphous & Form Y)
Gastro-Intestinal - GI
Vonoprazan Fumarate
Gastro-Intestinal - GI
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related Resources
Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security
For more than two decades, Dr. Reddy's has been recognized as one of the largest manufacturers of H2 receptor antagonist APIs such as Famotidine and Nizatidine. Our Tidine APIs are used by formulation companies across Europe, US, Japan, Middle-East and Asia Pacific.Manufactured and controlled in accordance with the international guidelines on nitrosamine impurities, these APIs are available in customized particle size distribution to ideally meet your formulation needs.Read the tech sheet on Famotidine and Nizatidine by filling the contact form below.You can also explore our Tidine API offerings by clicking on the links below:Famotidine: https://api.drreddys.com/product/famotidineNizatidine: https://api.drreddys.com/product/nizatidine
